chitosan has been researched along with lenvatinib in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Han, G; Hao, X; Liu, H; Rong, D; Shi, X; Tang, W; Wang, X; Zhang, C; Zhang, Y; Zheng, Z | 1 |
1 other study(ies) available for chitosan and lenvatinib
| Article | Year |
|---|---|
CircPAK1 promotes the progression of hepatocellular carcinoma via modulation of YAP nucleus localization by interacting with 14-3-3ΞΆ.
Topics: 14-3-3 Proteins; Animals; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Chitosan; Gene Expression Regulation, Neoplastic; Liver Neoplasms; Phenylurea Compounds; Protein Serine-Threonine Kinases; Quinolines; RNA, Circular; RNA, Untranslated; Transcription Factors | 2022 |